Amphastar Pharmaceuticals (AMPH) Lags Q3 Earnings and Revenue Estimates
Portfolio Pulse from
Amphastar Pharmaceuticals (AMPH) reported Q3 earnings of $0.96 per share, missing the Zacks Consensus Estimate of $1.01 per share. This is a decrease from $1.15 per share a year ago.
November 06, 2024 | 11:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Amphastar Pharmaceuticals reported Q3 earnings of $0.96 per share, missing estimates and showing a decline from last year's $1.15 per share.
The earnings miss and year-over-year decline in EPS are likely to negatively impact Amphastar's stock price in the short term as investors react to the underperformance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100